Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response.

Lee AA., Amick I., Aschenbrenner JC., Barr HM., Benjamin J., Brandis A., Cohen G., Diaz-Tapia R., Duberstein S., Dixon J., Cousins D., Fairhead M., Fearon D., Frick J., Gayvert J., Godoy AS., Griffin EJ., Huber K., Koekemoer L., Lahav N., Marples PG., McGovern BL., Mehlman T., Robinson MC., Singh U., Szommer T., Tomlinson CWE., Vargo T., von Delft F., Wang S., White K., Williams E., Winokan M.

DOI

10.1101/2024.08.19.608619

Type

Preprint

Publication Date

21/08/2024

Permalink Original publication